...
首页> 外文期刊>Tumour biology : >BMI, apolipoprotein B/apolipoprotein A-I ratio, and insulin resistance in patients with prolactinomas: a pilot study in a Chinese cohort.
【24h】

BMI, apolipoprotein B/apolipoprotein A-I ratio, and insulin resistance in patients with prolactinomas: a pilot study in a Chinese cohort.

机译:泌乳素瘤患者的BMI,载脂蛋白B /载脂蛋白A-I比值和胰岛素抵抗:在中国队列研究中的一项初步研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Deranged metabolic profiles and insulin resistance (IR) have been documented in patients with prolactinomas. Few data are yet available on the apolipoprotein (apo) B/apoA-I ratio and its relationship with IR in patients with prolactinomas. This study was aimed to evaluate the level of apoB/apoA-I ratio and its association with IR in a Chinese subgroup with prolactinomas. Twenty-three prolactinoma patients and 20 healthy controls were enrolled in this study. The clinical anthropometric parameters and laboratory evaluation were collected. Insulin sensitivity was estimated using homeostatic model assessment [homeostasis model assessment of insulin resistance (HOMA-IR)]. Waist circumference and body weight index (BMI) were significantly higher in patients with prolactinomas than those in the controls (p?
机译:泌乳素瘤患者有新陈代谢紊乱和胰岛素抵抗(IR)的记录。催乳素瘤患者中载脂蛋白(apo)B / apoA-I比率及其与IR的关系的数据很少。这项研究旨在评估中国催乳素瘤亚组中apoB / apoA-I的水平及其与IR的关系。本研究招募了23名泌乳素瘤患者和20名健康对照。收集临床人体测量学参数和实验室评估。使用稳态模型评估[胰岛素抵抗的稳态模型评估(HOMA-IR)]评估胰岛素敏感性。泌乳素瘤患者的腰围和体重指数(BMI)明显高于对照组(p <0.05)。同时,与健康受试者相比,男性患者的普遍肥胖和腹部肥胖的患病率似乎更为明显(分别为57.14%vs. 0%和71.43%vs. 16.7%)。此外,催乳素瘤患者的空腹血糖,胰岛素,HOMA-IR,甘油三酸酯和apoB / apoA-I比率也显着较高,但apoA-I水平较低(p <0.05)。单因素回归分析显示催乳素,腰围,BMI和性腺功能减退的存在与IR显着相关(p <0.05)。但是,只有BMI [几率(OR)?=?1.937,95?%置信区间(CI)1.112-3.375,p?=?0.02)和催乳素(OR?=?5.173,95?%CI 1.073-24.94, p?=?0.041)是多元逻辑分析中IR存在的独立预测因子。这项研究证实了催乳素瘤患者的代谢特征发生了改变,包括体重增加,IR,脂质紊乱和载脂蛋白。催乳素和BMI与IR独立相关。 apoB / apoA-I比值对IR的影响有待进一步研究确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号